Apr 24, 2026 04:47PM
Mar 9, 2026 08:07AM
Feb 5, 2026 04:02PM
Feb 4, 2026 04:15AM
Jan 6, 2026 08:33AM
Jan 6, 2026 08:31AM
Jul 22, 2025 08:36AM Coeptis extinguishes convertible note debt with YA II PN
May 28, 2025 08:28AM
May 12, 2025 08:20AM
Apr 28, 2025 01:35PM
Apr 25, 2025 08:38AM
Apr 17, 2025 08:39AM
Apr 15, 2025 08:33AM
Apr 4, 2025 06:25AM Coeptis Therapeutics (COEP) files for 3.92M Share Offering by Selling Stockholders
Mar 11, 2025 08:35AM
Mar 7, 2025 08:38AM
Feb 19, 2025 04:00PM
Feb 13, 2025 08:39AM
Jan 30, 2025 08:27AM
Jan 23, 2025 08:11AM
Jan 7, 2025 08:04AM Coeptis Therapeutics (COEP) Announces First Customer Adoptions of its NexGenAI Marketing Platform
Dec 27, 2024 08:15AM
Dec 26, 2024 08:16AM
Dec 12, 2024 08:01AM
Dec 3, 2024 08:16AM
Oct 24, 2024 08:07AM
Sep 19, 2024 07:07AM
Sep 5, 2024 08:08AM Coeptis Therapeutics (COEP) Chief Executive Officer, Dave Mehalick, Updates and Outlines Strategic Vision in Letter to Shareholders
Jun 17, 2024 02:03PM

409,078 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All